Molecular Diagnosis & Therapy provides researchers and healthcare professionals with insights into the latest molecular diagnostic and therapeutic techniques and their use in precision medicine.

Via a program of reviews and original research articles, the journal is focused on linking diagnostic and prognostic biomarkers to appropriate therapy, with an emphasis on the development of companion diagnostic/therapeutic products, along with the analysis of pharmacogenomic data for drug development and therapeutic decision making.

Molecular Drugs & Therapy offers a range of additional features designed to increase the visibility, readership and educational value of the journal’s content. Each article is accompanied by a Key Points summary, giving a time-efficient overview of the content to a wide readership. Articles may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand the scientific content and overall implications of the article. The journal also provides the option to include various types of digital features including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations. All additional features are peer reviewed to the same high standard as the article itself. Peer review is conducted using Editorial Manager®, supported by a database of international experts. This database is shared with other Adis journals.

There are no publication charges for standard publishing in Molecular Diagnosis & Therapy; the journal offers the option of Open Access publication via Springer Open Choice (article processing charge €3,060 / US$3,860). Please click on the link below under ‘Publishing model’ for further information about this service.

Journal information

Editor
  • Alison Fitches
Publishing model
Hybrid. Open Access options available

Journal metrics

3.058 (2018)
Impact factor
2.650 (2018)
Five year impact factor
19 days
Submission to first decision
90 days
Submission to acceptance
41,541 (2018)
Downloads

Latest articles

This journal has 48 open access articles

About this journal

Electronic ISSN
1179-2000
Print ISSN
1177-1062
Abstracted and indexed in
  1. CNKI
  2. Chemical Abstracts Service (CAS)
  3. Current Contents/ Life Sciences
  4. EBSCO Academic Search
  5. EBSCO Discovery Service
  6. EBSCO STM Source
  7. EMBASE
  8. EMBiology
  9. Elsevier Biobase
  10. Google Scholar
  11. Institute of Scientific and Technical Information of China
  12. Japanese Science and Technology Agency (JST)
  13. Journal Citation Reports/Science Edition
  14. Medline
  15. Meta
  16. Naver
  17. OCLC WorldCat Discovery Service
  18. Pathway Studio
  19. ProQuest Agricultural & Environmental Science Database
  20. ProQuest Biological Science Database
  21. ProQuest Biotechnology Research Abstracts
  22. ProQuest Central
  23. ProQuest Engineering
  24. ProQuest Environmental Science
  25. ProQuest Health & Medical Collection
  26. ProQuest Health Research Premium Collection
  27. ProQuest Materials Science and Engineering Database
  28. ProQuest Medical Database
  29. ProQuest Natural Science Collection
  30. ProQuest SciTech Premium Collection
  31. ProQuest Technology Collection
  32. ProQuest-ExLibris Primo
  33. ProQuest-ExLibris Summon
  34. Reaxys
  35. SCImago
  36. SCOPUS
  37. Science Citation Index Expanded (SciSearch)
Copyright information

Rights and permissions

Springer policies

© Springer Nature Switzerland AG